Abstract:Abstract Krüppel-like factor 5 (KLF5) is an evolutionarily conserved zinc finger-containing transcription factor promoting breast cell proliferation, survival, and tumor growth through upregulating its target gene FGF-BP. The protein abundance of KLF5 has been shown to be strictly regulated at transcriptional and posttranslational levels. Our previous studies suggest that the KLF5 protein degradation is through the ubiquitin proteasome pathway. The WWP1 E3 ligase can target KLF5 for ubiquitin-mediated proteasomal degradation. In this study, we demonstrated the F-box protein FBW7 targets KLF5 for proteolysis and suppresses KLF5's functions in breast cancer. The SCFFBW7 (SKP1-Cullin1-F-box) E3 ligase complex has been shown to target several oncoproteins, including MYC and CyclinE, for proteolysis. FBW7 could be a tumor suppressor due to its frequent mutations in multiple cancers. Here, we first demonstrated that inactivation of endogenous FBW7 by gene knockout, knockdown, or mutation remarkably increases the endogenous KLF5 protein abundances through blocking its degradation in multiple cell lines. Second, we found that overexpression of FBW7 decreases the exogenous and endogenous KLF5 protein levels in HEK293T and SUM149PT cell lines. Functionally, overexpression of FBW7 in the endogenous FBW7 mutated SUM149PT cells decreases the FGF-BP gene expression and the DNA synthesis. Importantly, knockdown of endogenous Fbw7 increases the FGF-BP gene expression, cell proliferation, and survival through upregulating the KLF5 expression in breast cells. These findings suggest that the Fbw7 tumor suppressor inhibit breast cancer cell proliferation and survival at least partially through targeting KLF5 for ubiquitin-mediated degradation. This new regulatory mechanism of KLF5 degradation may result in useful diagnostic and therapeutic targets for breast cancer and other cancers. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3155.

Krupple-Like Factor 5 Promotes Breast Cancer Proliferation Through Activating Fibroblast Growth Factor-Binding Protein Transcription

Krüppel-like Factor 5 Promotes Breast Cell Proliferation Partially Through Upregulating the Transcription of Fibroblast Growth Factor Binding Protein 1.

Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma

KLF5 Promotes Breast Cell Survival Partially Through Fibroblast Growth Factor-Binding Protein 1-Perk-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization.

KLF4 Downregulates Htert Expression and Telomerase Activity to Inhibit Lung Carcinoma Growth.

KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer

KLF5 Promotes Breast Cancer Proliferation, Migration and Invasion in Part by Upregulating the Transcription of TNFAIP2

Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy

KLF5 Promotes Cell Proliferation and Tumorigenesis Through Gene Regulationin the TSU-Pr1 Human Bladder Cancer Cell Line

Krüppel-Like Factor 5 Promotes Lung Tumorigenesis Through Upregulation of Sox4

lncRNA ENST00000422059 promotes cell proliferation and inhibits cell apoptosis in breast cancer by regulating the miR-145-5p/KLF5 axis

KLF5 is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells

KLF15 Suppresses Tumor Growth and Metastasis in Triple-Negative Breast Cancer by Downregulating CCL2 and CCL7.

Krüppel-like Factor 5 Promotes the Progression of Oral Squamous Cell Carcinoma Via the Baculoviral IAP Repeat Containing 5 Gene.

Kruppel-like factors in breast cancer: Function, regulation and clinical relevance

Abstract 3155: the SCFFBW7 E3 Ubiquitin Ligase Targets Krüppel-like Factor 5 (KLF5) for Proteolysis in Breast Cancer

Krüppel-like factors in breast cancer: Function, regulation and clinical relevance

A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer

Mechanism of transcription factor KLF5 mediating acquired drug resistance in breast cancer cells

KLF5 Is a Positive Regulator of Cell Proliferation in Gastric Cancer and Correlates with More Aggressive Disease

Beyond Proliferation: KLF5 Promotes Angiogenesis of Bladder Cancer Through Directly Regulating VEGFA Transcription